The global bone growth stimulator market size is expected to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. Escalating demand for noninvasive and minimally invasive treatments is a major factor estimated to boost market growth during the forecast period. Some advantages offered by minimally invasive surgeries are smaller incisions, low risk of infections, speedy recovery, shorter stay at the hospital, reduced scarring, and minimal blood loss during surgery. Thus, there is high adoption of Bone Morphogenetic Proteins (BMP) and Platelet-rich Plasma (PRP) for minimally invasive spinal and orthopedic surgeries, which is expected to boost the market growth.
The
rising number of trauma and accident cases is another major factor projected to
support the growth of the bone growth stimulator market. According to WHO,
around 20 to 50 million people are injured every year due to road accidents.
Road accidents and trauma are likely to result in severe spinal injuries as
well as delayed union or nonunion of bone fractures, which is projected to
drive demand for bone growth stimulators.
Full Research Report On Bone Growth Stimulators Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/bone-growth-stimulator-market
Further Key
Findings From the Report Suggest:
- Bone growth stimulation
devices segment was the largest revenue grossing segment of the market in
2016 owing to high demand for noninvasive treatments by patients as well
as product advancements
- PRP segment is estimated to
grow at the highest CAGR during the forecast period owing to its growing
popularity for bone and soft tissue healing, as well as its favorable
safety profile and potential promising outcome for the development of
regenerative treatments
- In the application segment,
the spinal fusion surgeries segment accounted for the largest share in
2016 and is projected to maintain its dominance during the forecast period
owing to the escalating number of spinal injuries, fractures, and spinal
stenosis
- The hospitals segment
accounted for the largest share in the overall market and is expected to
maintain its dominance during the study period due to escalating number of
admissions of patients suffering from traumatic injuries, road accidents,
spinal injuries, and bone fractures
- North America dominated the
overall market in 2016 mainly due to the existence of several leading
medical device companies in this region and highly developed healthcare
infrastructure
- The Asia Pacific bone growth
stimulator market is projected to grow at the highest rate during the
forecast period. The rising number of road accidents and developing
healthcare infrastructure in Asian countries, including China, India, and
Indonesia, are major factors contributing to growth in this region
- Some of the major players
are Orthofix Holdings, Inc.; Medtronic; Zimmer Biomet; DJO Global, Inc;
Bioventus; Stryker; DePuy Synthes Companies; Arthrex, Inc.; Isto
Biologics; and Terumo BCT, Inc.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/bone-growth-stimulator-market/request/rs1
Grand View Research has segmented
the global bone growth stimulator market on the basis of product, application,
end use, and region:
Bone Growth
Stimulator Product Outlook (Revenue, USD Million; 2014 - 2025)
- Bone growth stimulation
devices
- External bone growth
stimulators
- Combined Magnetic Field
(CMF) devices
- Capacitive Coupling (CC)
devices
- Pulsed Electromagnetic
Field (PEMF) devices
- Implanted bone growth
stimulators
- Ultrasonic bone growth
stimulators
- Bone Morphogenetic Proteins
(BMP)
- Platelet-rich Plasma (PRP)
Bone Growth
Stimulator Application Outlook (Revenue, USD Million; 2014 - 2025)
- Spinal fusion surgeries
- Delayed union & nonunion
bone fractures
- Oral and maxillofacial
surgeries
- Others
Bone Growth
Stimulator End-Use Outlook (Revenue, USD Million; 2014 - 2025)
- Hospitals and clinics
- Home care
- Others
Bone Growth
Stimulator Regional Outlook (Revenue, USD Million; 2014 - 2025)
- North America
- The U.S.
- Canada
- Europe
- Germany
- The U.K.
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
- Saudi Arabia
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment